Examples of 'beta-lactamase' in a sentence
Meaning of "beta-lactamase"
Beta-lactamase is an enzyme produced by some bacteria that confers resistance to beta-lactam antibiotics, such as penicillin. It works by breaking down the beta-lactam ring structure of these antibiotics, rendering them ineffective
Show more definitions
- An enzyme produced by certain bacteria, responsible for their resistance to beta-lactam antibiotics such as penicillin.
How to use "beta-lactamase" in a sentence
Basic
Advanced
beta-lactamase
Process for producing beta-lactamase inhibitor.
Beta-lactamase positive isolates should be reported resistant.
The AmpR gene is penicillin beta-lactamase.
Beta-lactamase types or classes are discussed herein above.
Bridged monobactams useful as beta-lactamase inhibitors.
Unbound beta-lactamase is removed and substrate is added.
They are also more resistant to beta-lactamase.
Beta-lactamase are rarely useful for any other purpose.
Clavulanic acid is a known beta-lactamase inhibitor.
The beta-lactamase could be encoded in chromosomal or plasmidic genes.
The carboxypenicillins are beta-lactamase sensitive.
A suitable beta-lactamase substrate is any beta lactam antibiotic.
The ampicillin resistance gene is penicillin beta-lactamase.
This is a drug combination of a beta-lactamase inhibitor and ampicillin.
The beta-lactamase gene which provides ampicillin resistance.
See also
Each domain is composed of a beta-lactamase type fold.
Beta-lactamase provides antibiotic resistance by breaking the antibiotics ' structure.
Cefquinome is resistant to beta-lactamase.
It inactivates some beta-lactamase enzymes thereby preventing inactivation of amoxicillin.
Bacteria are known to produce several types of beta-lactamase enzymes.
A gene encoding the beta-lactamase protein is present on the plasmids.
In addition tazobactam does not inhibit the following types of beta-lactamase.
Beta-lactamase inhibitor and process for preparing the same.
The two alleles of the beta-lactamase gene were constructed as follows.
As a result, this enzyme improves the effectiveness of beta-lactamase antibiotics.
This plasmid contains the beta-lactamase gene for ampicillin resistance.
In some embodiments, the additional antibiotic can be a beta-lactamase inhibitor.
Clavulanic acid is a beta-lactamase inhibitor acting initially competitively but ultimately irreversibly.
More preferably, the enzymatic degradation is due to degradation by a beta-lactamase.
The acid is suicide inhibitor of bacterial beta-lactamase enzymes from streptomyces clavuligerus.
The beta-lactamase produced by the new sea bacterium meets these conditions.
Amoxicillin is sometimes used with clavulanic acid which is beta-lactamase inhibitor.
Typical examples of beta-lactamase inhibitors include sulbactam, tazobactam and clavulanic acid.
Polymicrobial infections often include pathogens that produce beta-lactamase enzymes.
The second requirement of a beta-lactamase or a product thereof is to hydrolyze beta-lactam efficiently.
Alternatively, samples also include material in which a beta-lactamase has been added.
These include beta-lactamase for antibiotics research, cytosolic sulphotransferases as well as a therapeutic lipase.
The cleavage site of the linker may be a substrate of a beta-lactamase of a pathogen.
Aureus beta-lactamase can hydrolyze p-nitrophenyl phosphonate esters with single turnover kinetics.
The present invention relates to a method of modifying a beta-lactamase as defined in claim 2.
The production of beta-lactamase is the most important mechanism of bacterial resistance to beta-lactam antibiotics.
The cleavage site of the linker can be a substrate of a beta-lactamase of a pathogen.
If a cell expresses a beta-lactamase reporter gene, the expressed enzyme will cleave the substrate.
The carbapenems were developed to overcome antibiotic resistance mediated by bacterial beta-lactamase enzymes.
Twenty strains were tested for presence of beta-lactamase by the indirect fluorescent antibody technique.
The mechanism of resistance for these strains is believed to be hyper-production of beta-lactamase.
All clones that showed repressed beta-lactamase expression showed repressed beta-lactamase mRNA.
The pharmaceutical composition of the invention comprises the beta-lactamase of the invention.
All clones that had beta-lactamase enzyme inducibility tested showed beta-lactamase mRNA inducibility.
Further, methods are provided for determining the amount of beta-lactamase activity in a cell.
